57 %Youth living with HIV who had self-disclosed reported elevated depressive symptoms at a prevalence of 57%, compared to 30% among those who had not self-disclosed.
KenyaVIH/sidapublished 2021AIDS and behaviorPubMeddocument of 13 observations
Gold tier: mechanically validated evidence, with its primary source.
2,235 evidence items · page 57 / 90
57 %Youth living with HIV who had self-disclosed reported elevated depressive symptoms at a prevalence of 57%, compared to 30% among those who had not self-disclosed.
KenyaVIH/sidapublished 2021AIDS and behaviorPubMeddocument of 13 observations
124 cells/μLIn 102 antiretroviral-naïve Kenyan women with advanced HIV-1 infection, the median CD4 count was 124 cells/μL.
KenyaVIH/sidapublished 2013BMC infectious diseaseseurope_pmcdocument of 3 observations
37 %M184I was the most prevalent clinically important HIV drug resistance variant, seen in 37% of ART-naïve women from the Pumwani Sex Worker cohort of Nairobi, Kenya.
KenyaVIH/sidapublished 2022VirusesPubMeddocument of 4 observations
14.3 %Of 1,200 registered cancer cases, 171 cases (14.3%) met clinical strength-of-evidence criteria for association with HIV infection/AIDS.
Kenyacancer (non précisé) · VIH/sidaobserved August 1 to October 31, 2011published 2014PloS oneeurope_pmcdocument of 4 observations
73.5 %Among 3891 PLHIV with documented IPT treatment outcomes in Kenya between July 2015 and June 2018, follow-up for active tuberculosis at 6-month post-IPT completion was done for 2729 (73.5%).
Kenyatuberculose · VIH/sidaobserved July 2015 to June 2018published 2020PloS onePubMeddocument of 8 observations
18 US$The mean total unit cost of HIV testing services (HTS) was US$18 in Kenya.
KenyaVIH/sidaobserved 2019published 2023BMC health services researchPubMeddocument of 11 observations
0.1 %Only 0.1% of AFRICOS participants reported men who have sex with men (MSM) as a risk factor.
KenyaVIH/sidapublished 2022PloS onePubMeddocument of 13 observations
87 %Among people with HIV reporting hazardous alcohol use, the intervention arm had viral suppression of 87% compared with 72% in the control arm.
KenyaVIH/sidapublished 2023Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 6 observations
37 %Among 642 HIV-positive female sex workers eligible for IPT evaluation, 236 (37%) were cascade losses.
KenyaVIH/sidaobserved between March 2000 and January 2010published 2017Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 9 observationsDOI 10.1097/qai.0000000000001461
1,549 participants1549 participants were included in the analysis.
KenyaVIH/sidapublished 2023The lancet. HIVPubMeddocument of 8 observations
21.5 %HIV prevalence increased from 21.5% to 26.2% among widowed women in Siaya County, Kenya between 2011 and 2022.
KenyaVIH/sidaobserved 2011-2022published 2025BMC public healthPubMeddocument of 12 observations
85 %In the SEARCH Study in rural Kenya and Uganda (2013–2017), 85% of HIV-positive persons had viral suppression at year 2 according to unadjusted estimates.
KenyaVIH/sidaobserved 2013-2017published 2020Epidemiology (Cambridge, Mass.)PubMeddocument of 8 observations
10 %Among 607 survey responders (86% of 704 seroconverters), 10% of women reported transactional sex as the suspected infection source.
KenyaVIH/sidapublished 2021PloS onePubMeddocument of 16 observations
4,201 individualsAmong 4201 adolescents and youth living with HIV (AYLHIV) in Kenya between January 2016 and December 2017, 1452 (35%) were newly enrolled and 2749 (65%) had been on antiretroviral therapy (ART) for ≥2 years.
KenyaVIH/sidaobserved 2016-2017published 2023AIDS patient care and STDsPubMeddocument of 5 observations
1,729 per_one_million_T_cellsIn a cohort of Kenyan children (n = 72), the median number of total HIV proviral copies was 1729 per one million T cells between one- and two-years post-ART initiation.
KenyaVIH/sidapublished 2023VirusesPubMeddocument of 3 observations
1.68 RRSuperinfected individuals develop significantly broader neutralizing antibody responses post-superinfection compared to singly infected individuals, with a relative risk of 1.68.
KenyaVIH/sidapublished 2012PLoS pathogenseurope_pmcdocument of 3 observationsDOI 10.1371/journal.ppat.1002611
15.5 %HIV prevalence among pregnant women receiving HIV testing at antenatal care initiation was 15.5% between October 2016 and September 2021.
KenyaVIH/sidaobserved October 2016 to September 2021published 2024PLoS medicineeurope_pmcdocument of 5 observations
23.2 %Fifty-four (23.2%) patients had virological failure (>1000 copies/mL).
KenyaVIH/sidapublished 2022MedicinePubMeddocument of 7 observations
49 %Personnel accounted for 49% of the costs of integrating assisted partner services (aPS).
KenyaVIH/sidapublished 2022BMC health services researchPubMeddocument of 13 observations
29.4 %Among men who have sex with men living with HIV in Kenya, 29.4% of those who solely met partners via virtual sites (VMSM) were diagnosed and aware of their status.
KenyaVIH/sidaobserved 2019published 2020Journal of the International AIDS SocietyPubMeddocument of 12 observations
The odds of thrombocytopenia were decreased in HIV/malaria co-infection compared to the uninfected group.
Kenyapaludisme · thrombocytopenia · VIH/sidapublished 2023International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument of 8 observations
18 %Among 4597 enrolled partner participants, 597 (18%) had HIV.
KenyaVIH/sidapublished 2024The Lancet. Global healthPubMeddocument of 7 observations
421 cells/μlAt baseline, the mean CD4 count for HIV mono-infected individuals was 421 cells/μl.
KenyaVIH/sidapublished 2021Pan African Medical JournalOpenAlexdocument of 10 observations
0.37 odds_ratioAnaemia burden was lower in HIV-positive non-injection substance users compared to HIV-negative non-injection substance users, with an odds ratio of 0.37.
Kenyaanémie · VIH/sidapublished 2022African health sciencesPubMeddocument of 7 observations
1.29 timesIn Kenya, caregivers were 1.29 times more likely to receive early infant diagnosis (EID) results by 12 weeks of age with point-of-care (POC) versus laboratory-based EID.
KenyaVIH/sidapublished 2020Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 13 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.